Other COPD medication
Sponsors
AstraZeneca
Conditions
Pulmonary Disease, Chronic Obstructive
Unknown Phase
Aclidinium Bromide Post-Authorisation Safety Study to Evaluate the Risk of Cardiovascular Endpoints
CompletedNCT03290287
Start: 2017-03-01End: 2022-06-30Updated: 2023-01-31
A Drug Utilisation Post-authorisation Study of New Users of Aclidinium Bromide (Monotherapy or in Combination)
CompletedNCT03333018
Start: 2015-07-06End: 2017-02-28Updated: 2018-02-22